Malignant Mesothelioma
📧 Sign up to get email alerts when something new happens for Malignant Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-17Clinical Trial Results: Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma [Phase 2]
Phase II multi-drug trial (MiST) in malignant mesothelioma has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies [Phase 1]
Phase 1 trial evaluating CTX-471 as a monotherapy or in combination with pembrolizumab in patients who progressed after PD-1/PD-L1 inhibitor…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery [Phase 1]
A Phase 1 trial update describes light dosimetry for photodynamic therapy using porfimer sodium in participants with malignant mesothelioma …
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: ......SMARTEST Trial...... [Phase 2]
The SMARTEST trial, a Phase 2 study sponsored by University Health Network in Toronto, has completed. It investigated a treatment for malign…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: NM32-2668 in Adult Patients With Selected Advanced Solid Tumors [Phase 1]
A Phase 1 trial of NM32-2668 in adults with selected advanced solid tumors has been terminated. The study enrolled multiple tumor types incl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: CART-meso Long-term Follow-up
Clinical trial update reporting long-term follow-up data for subjects treated with lentiviral-based CART-meso therapy in mesothelioma, provi…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study. [Phase 2]
This Phase 2 trial assesses the feasibility of an early palliative care intervention for patients with metastatic cancer. The study has comp…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide [Phase 1]
Phase I dose-escalation study of azacitidine in combination with temozolomide in soft tissue sarcoma and mesothelioma has completed with res…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Niraparib Efficacy in Patient With Unresectable Mesothelioma [Phase 2]
Phase 2 clinical trial update shows Niraparib efficacy in a patient with unresectable malignant mesothelioma.
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients [EARLY_Phase 1]
Early-phase 1 clinical trial evaluating heated intraperitoneal chemotherapy with doxorubicin and cisplatin for pediatric abdominal/pelvic tu…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers [Phase 1]
Phase 1 study of cosibelimab (CK-301) as a single-agent therapy in adults with advanced cancers; the trial status is active but not recruiti…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: Dendritic Cell Vaccination for Patients with Solid Tumors [Phase 1, Phase 2]
Phase 1/Phase 2 clinical study evaluating a dendritic cell vaccine in patients with solid tumors, including glioblastoma and renal cell carc…
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma [Phase 1]
Phase 1 study of intra-pleural GL-ONC1, a genetically modified vaccinia virus, in patients with malignant pleural effusion including mesothe…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies [Phase 1]
Phase 1 trial update exploring pembrolizumab in combination with an autologous dendritic cell vaccine for PD-L1-negative malignant mesotheli…
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma [NA]
Completed clinical trial evaluating magnetic resonance imaging for detection of malignant mesothelioma, including peritoneal mesothelioma.
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study of PRT3645 conducted by Prelude Therapeutics in patients with several advanced solid tumors has completed, including breast …
-
CLINICAL_TRIALS trial_result · 2024-06-05Clinical Trial Update: Artificial Intelligence in Lung Cancer Screening
A completed clinical trial evaluating the use of artificial intelligence to improve lung cancer screening, including individuals with asbest…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of methoxyamine with cisplatin and pemetrexed disodium in patients with advanced solid tumors or …
-
CLINICAL_TRIALS trial_result · 2024-02-29Clinical Trial Update: Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma [Phase 2]
Phase 2 trial update evaluating nivolumab and ipilimumab with or without UV1 vaccination as second-line therapy for malignant mesothelioma.
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma [Phase 1]
Phase 1 trial evaluating intratumor LMB-100 with ipilimumab in mesothelioma; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma [Phase 2]
Phase II trial of nivolumab plus ramucirumab in previously treated malignant mesothelioma was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating stereotactic body radiation therapy combined with Avelumab immunotherapy for malignant mesot…
-
CLINICAL_TRIALS trial_result · 2023-10-04Clinical Trial Update: Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin [Phase 2, Phase 3]
Phase 2/3 trial in mesothelioma evaluating ADI-PEG 20 with pemetrexed and cisplatin completed, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma [Phase 2]
Phase II study overview for Mesothelioma Stratified Therapy (MiST), a multi-drug regimen trial in malignant mesothelioma.
-
CLINICAL_TRIALS trial_result · 2023-03-13Clinical Trial Update: Mesothelioma Avastin Plus Pemetrexed-cisplatin Study [Phase 2, Phase 3]
Clinical trial update for mesothelioma evaluating Avastin with pemetrexed-cisplatin in Phase 2 and Phase 3 completed.